Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Simon WalkerSteve Palmer

Abstract

Until recently, purchasers' options regarding whether to pay for the use of medical technologies have been binary in nature: a treatment is either covered or not. Policies, however, have emerged that expand the decision options, for example, linking coverage to evidence development, an option increasingly used for treatments with limited/uncertain evidence. There has been little effort to reconcile the features of technologies with the available decision options. We described a framework within which different decision options can be evaluated. We distinguished two sources of value in terms of health: the value of the technology per se and the value of reducing decision uncertainty. The costs of reversing decisions were also considered. Purchasers should weigh the expected benefits of coverage against the possibility that the decision may need to be reversed and the chance that adoption will hinder evidence generation. Based on the purchaser's range of authority over access, research, and price and on the characteristics of the technology with regard to reversibility and evidence, different decisions may be appropriate. The framework clarified the assessments needed to establish the appropriateness of different decisions. A tax...Continue Reading

References

Feb 24, 2001·Journal of Health Economics·S Palmer, P C Smith
Mar 29, 2003·BMJ : British Medical Journal·Stephen ChapmanRichard Neary
Aug 24, 2004·BMJ : British Medical Journal·Christine Y LuJames Bertouch
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Tanisha CarinoSean Tunis
Aug 17, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Gérard de Pouvourville
May 31, 2007·Health Economics·Karl Claxton
Feb 5, 2008·BMJ : British Medical Journal·Karl ClaxtonMark J Sculpher
May 16, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Simon Eckermann, Andrew R Willan
Jul 16, 2008·Journal of Health Economics·Anupam B Jena, Tomas J Philipson
Dec 18, 2008·Health Affairs·Arjun Jayadev, Joseph Stiglitz
Apr 28, 2009·Journal of the American College of Radiology : JACR·Sean Tunis, Danielle Whicher
May 29, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jenn-Yu WuPan-Chyr Yang
Jul 17, 2009·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Stefano Conti, Karl Claxton
Jan 22, 2010·The New England Journal of Medicine·Peter J Neumann, Sean R Tunis
Jan 22, 2010·Health Economics·Susan C GriffinMark J Sculpher
May 11, 2010·Journal of Public Economics·Darius Lakdawalla, Neeraj Sood
Jun 17, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·James D ChambersMartin J Buxton

❮ Previous
Next ❯

Citations

Jul 24, 2013·PharmacoEconomics·Christopher McCabePeter Hall
Oct 1, 2013·Lancet·Kjetil SøreideUNKNOWN International Research Collaboration in Surgery (IRIS) ad-hoc working group
Dec 1, 2013·Stem Cells and Development·Tania Bubela, Christopher McCabe
Mar 4, 2014·Journal of Medical Internet Research·Klemen Naveršnik, Aleš Mrhar
Mar 26, 2014·Applied Health Economics and Health Policy·Josh J CarlsonLouis P Garrison
Jun 13, 2014·International Journal of Technology Assessment in Health Care·Don HusereauJamil Jivraj
Mar 22, 2014·Journal of Medical Economics·Haitham W TuffahaPaul A Scuffham
Jun 27, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Katarzyna KolasaEdward Hornby
Nov 8, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yolande LievensFrank Hulstaert
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nicolas MartelliIsabelle Borget
May 15, 2013·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Claudia Wild, Anna Nachtnebel
Mar 16, 2016·International Journal of Technology Assessment in Health Care·Alina BrandesWolf H Rogowski
Jul 31, 2014·International Journal of Clinical Practice·C Y Lu
Jun 28, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard EdlinChristopher McCabe
Mar 31, 2015·Journal of Pharmaceutical Policy and Practice·Christine Y LuAnita K Wagner
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonMiguel Sleeper
Jan 7, 2017·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sabine E GrimmJohn W Stevens
Oct 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan R R LewisWendy Lipworth
Mar 24, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Christopher JacksonLinda Sharples
Feb 27, 2018·PharmacoEconomics·Haitham W Tuffaha, Paul A Scuffham
Dec 27, 2017·International Journal of Technology Assessment in Health Care·Maxine F RobinsonElizabeth Roughead
Aug 11, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Christine Y LuMuin J Khoury
Jul 14, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Hussain Abdulrahman Al-OmarIbrahim Abdulrahman Aljuffali
Sep 24, 2020·International Journal of Technology Assessment in Health Care·Weiwei Xu, Jing Wu
Sep 20, 2019·PharmacoEconomics·Fernando AntonanzasRoberto Rodríguez-Ibeas
May 8, 2020·Applied Health Economics and Health Policy·Paula K Lorgelly, Amanda Adler
Apr 11, 2018·Frontiers in Pharmacology·Jacoline C BouvySarah Garner
Jul 19, 2019·Health Economics Review·Reyes LorenteRoberto Rodriguez-Ibeas
Jan 24, 2019·International Journal of Environmental Research and Public Health·Seung-Lai YooDong-Churl Suh
Jul 12, 2017·PharmacoEconomics·Josh J CarlsonLouis P Garrison
Feb 13, 2019·PharmacoEconomics·Matthew FranklinTracey Young
Jan 5, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bengt Jönsson
Mar 3, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Elisabeth FenwickClaire Rothery

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medical Decision Making : an International Journal of the Society for Medical Decision Making
Simon Eckermann, Andrew R Willan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
Gérard de Pouvourville
Medical Decision Making : an International Journal of the Society for Medical Decision Making
Joke BilckeMark Jit
© 2021 Meta ULC. All rights reserved